Physicians achieve 95% cure rate for sickle cell disease with bone marrow transplant
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with low rejection rates and also…
A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with low rejection rates and also…
Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them closer to…
A new study suggests the number of deaths due to sickle cell disease is 11 times higher than what is…